Correlation Engine 2.0
Clear Search sequence regions


  • abcg2 protein, human (1)
  • allele (1)
  • ATP (4)
  • BCRP (14)
  • cell membrane (1)
  • cytoplasm (1)
  • fetus (1)
  • gene (1)
  • human (3)
  • indoles (2)
  • neoplasm proteins (2)
  • placenta (2)
  • protein human (1)
  • Sizes of these terms reflect their relevance to your search.

    The antidiabetic agent glyburide (glibenclamide) is frequently used for the treatment of type II diabetes and is increasingly being used for the treatment of gestational diabetes. Evidence suggests that breast cancer resistance protein/ATP-binding cassette, subfamily G, member 2 (ABCG2) expressed in the placenta protects the fetus against the accumulation of glyburide. A number of studies have investigated the significance of several single-nucleotide polymorphisms (SNPs) in the ABCG2 gene. Associations between the Q141K (C421A) SNP and ABCG2 protein expression, membrane surface translocation, efflux activity, or ATPase activity have been shown. Therefore, alterations in glyburide transport across the placenta, resulting in increased fetal glyburide exposure, may be seen in individuals carrying the C421A allele. The purpose of this study is to investigate whether the Q141K SNP causes alterations in ABCG2-mediated glyburide transport. Glyburide accumulation assays were carried out with stably transfected human embryonic kidney (HEK)-293 cells expressing wild-type ABCG2 (Arg482) and polymorphic ABCG2 (Q141K). Glyburide kinetic parameters were determined for comparison of wild-type and SNP ABCG2 activity by simultaneously fitting data for ABCG2-expressing cells (saturable transport) and empty vector-expressing cells (nonsaturable transport) by nonlinear regression analysis. The apparent K(t) and V(max) values for the transfected HEK-293 cells expressing the polymorphic variant (Q141K) of ABCG2 were significantly higher than those values determined for the wild-type ABCG2-expressing cells (p < 0.05). Our results indicate that the Q141K variant of ABCG2 may have the potential to alter the placental pharmacokinetics of glyburide used in pregnancy.

    Citation

    Erika K Pollex, Gregory Anger, Janine Hutson, Gideon Koren, Micheline Piquette-Miller. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism. Drug metabolism and disposition: the biological fate of chemicals. 2010 May;38(5):740-4

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 20159988

    View Full Text